RXI Pharma Balance Sheet - Annual (NASDAQ:RXII)

Add to My Stocks
$1.24 $0.06 (5.08%) RXII stock closing price Sep 19, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like RXI Pharma, and helps in stock analysis. As in our RXI Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The balance sheet shows total liabilities of $2.26M and shareholders equity of $1.83M. RXI Pharma revenue and RXI Pharma operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check RXI Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Cash3.63M12.95M5.16M8.54M11.44M5.18M-
Marketable Securities--5.5M-3M--
Receivables-------
Inventory-------
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets-------
Total Current Assets
3.83M13.1M10.97M8.98M14.74M5.39M1.33M
Property Plant & Equipment------1M
Accumulated Depreciation-------
Net Property Plant & Equipment
-------
Investment & Advances-------
Other Non-Current Assets-------
Deferred Charges-------
Intangibles-------
Deposits & Other Assets-------
Total Assets
4.09M13.39M11.15M9.18M14.93M5.59M1.69M
Notes Payable-------
Accounts Payable--1.16M----
Current Portion Long-Term Debt-------
Current Portion Capital Leases-------
Accrued Expenses1.75M1.62M1.1M1M1.79M--
Income Taxes Payable-------
Other Current Liabilities-------
Total Current Liabilities
2.26M2.54M2.26M1.33M2.07M1.67M1.77M
Mortgages-------
Deferred Taxes/Income-------
Convertible Debt-------
Long-Term Debt-------
Non-Current Capital Leases-------
Other Long-Term Liabilities-------
Total Liabilities
2.26M2.54M2.26M1.33M2.07M1.7M2.28M
Minority Interest-------
Preferred Stock-3.52M-6.68M9.97M9.72M-
Common Stock Net-------
Capital Surplus80.38M73.42M65.98M48.04M40.96M11.3M3.68M
Retained Earnings-78.55M-66.09M-57.1M-46.88M-38.08M-17.15M-4.27M
Treasury Stock-------
Other Liabilities-------
Shareholders Equity1.83M10.85M8.89M7.85M12.86M3.88M-0.58M
Total Liabilities & Shareholders Equity4.09M13.39M11.15M9.18M14.93M5.59M1.69M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the RXI Pharma stock price by looking at RXI Pharma historical stock prices. One can compare PE with industry average by looking at the RXI Pharma PE ratio chart. The common balance sheet items are:

  • Assets: Anything that the RXI Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. RXI Pharma had total assets of $4.09M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. RXII stock had total liabilities of $2.26M for the year 2017.

RXI Pharma Balance Sheet - Key Ratios

Current ratio
2.11
Debt to equity ratio
0
Asset turnover ratio
0.05
Receivables turnover
0